<prompt> Answer this question truthfullyWhat is the adverse hematologic effect associated with GPIIbIIIa inhibitors?  <response>: <reason> The adverse hematologic effect associated with GPIIbIIIa inhibitors is thrombocytopenia. GPIIbIIIa inhibitors are a class of medications used to prevent blood clots by blocking the platelet glycoprotein IIbIIIa receptor. Thrombocytopenia is a condition characterized by a low platelet count in the blood, which can increase the risk of bleeding and bruising. Treatment for thrombocytopenia may involve discontinuing the use of GPIIbIIIa inhibitors and administering platelet transfusions or other medications to promote platelet production. 